Survival rates, including overall survival (OS) and progression-free survival (PFS), are key indicators of treatment effectiveness. OS refers to the length of time from diagnosis or start of treatment that patients are still alive, while PFS measures the time during and after treatment that a patient lives with the disease without it getting worse. These metrics are critical for evaluating long-term outcomes and making treatment decisions.
